Physician profile
Jane Nightengale
NPI 1437887387
$1,552.47
in general payments reported to CMS, 2019-2025
11 companies · $91.76 in 2025
The $91.76 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,126 · 2024: $334 · 2025: $91.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,204 · Travel and Lodging: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,204.44 |
| Travel and Lodging | $348.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $793.97 | 2023-2024 | Barostim Neo System |
| Atricure, INC. | $229.43 | 2023-2025 | Synergy Ablation System |
| Edwards Lifesciences Corporation | $128.97 | 2023 | Hemosphere |
| Kci USA, INC. | $99.65 | 2023 | Prevena |
| Baxter Healthcare | $73.86 | 2024-2025 | Preveleak |
| Abiomed | $58.14 | 2024 | Impella |
| Medtronic, INC. | $49.74 | 2024 | Sonicision |
| Stryker Corporation | $42.59 | 2024 | 1788 |
| Cerus Corporation | $33.57 | 2023 | Intercept Blood System For Platelets |
| On Target Laboratories, INC | $26.32 | 2025 | Cytalux |
| Ethicon US, LLC | $16.23 | 2025 | Ethicon, Prolene |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Nightengale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.